Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorna Rettig

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Vaccine|April 8, 2011
The form of NY-ESO-1 antigen has an impact on the clinical efficacy of anti-tumor vaccinationIana Parvanova, Lorna Rettig, Alexander Knuth, et al.
International Journal of Cancer|June 29, 2011
Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cellsLorna Rettig, Samuel Seidenberg, Iana Parvanova, et al.
Inflammation & Allergy Drug Targets|December 16, 2006
Immunotherapeutic targeting of allergic diseaseGabriela Senti, Julia M Martínez Gómez, Lorna Rettig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
An essential role for the stalk region of CD8 beta in the coreceptor function of CD8Lorna Rettig, Louise McNeill, Nitza Sarner, et al.
Blood|March 23, 2010
Particle size and activation threshold: a new dimension of danger signalingLorna Rettig, Sebastian P Haen, Anne Greet Bittermann, et al.
European Journal of Immunology|May 17, 2007
CD8alpha/alpha homodimers fail to function as co-receptor for a CD8-dependent TCRAnne-Marie McNicol, Gavin Bendle, Angelika Holler, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2008
Antigen kinetics determines immune reactivityPål Johansen, Tazio Storni, Lorna Rettig, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Vaccine|April 8, 2011
The form of NY-ESO-1 antigen has an impact on the clinical efficacy of anti-tumor vaccinationIana Parvanova, Lorna Rettig, Alexander Knuth, et al.
International Journal of Cancer|June 29, 2011
Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cellsLorna Rettig, Samuel Seidenberg, Iana Parvanova, et al.
Inflammation & Allergy Drug Targets|December 16, 2006
Immunotherapeutic targeting of allergic diseaseGabriela Senti, Julia M Martínez Gómez, Lorna Rettig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
An essential role for the stalk region of CD8 beta in the coreceptor function of CD8Lorna Rettig, Louise McNeill, Nitza Sarner, et al.
Blood|March 23, 2010
Particle size and activation threshold: a new dimension of danger signalingLorna Rettig, Sebastian P Haen, Anne Greet Bittermann, et al.
European Journal of Immunology|May 17, 2007
CD8alpha/alpha homodimers fail to function as co-receptor for a CD8-dependent TCRAnne-Marie McNicol, Gavin Bendle, Angelika Holler, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2008
Antigen kinetics determines immune reactivityPål Johansen, Tazio Storni, Lorna Rettig, et al.
Pageof 1